DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Mitry E. et al.
Bevacizumab plus capecitabine in patients with progressive advanced well-differenziated neuroendocrine tumors of the gastro-intestinal (GI-NETs) tract (BETTER trial)--a phase II non-randomised trial.
Eur J Cancer 2014;
50: 3107-3115
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.